Dalton and Zafgen Enter Manufacturing Pact

Dalton Pharma Services announced that it has entered into a manufacturing services agreement with Zafgen Inc.

Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider, has inked a manufacturing services agreement with Zafgen, Inc., a specialty pharma company based in Cambridge, MA, to provide cGMP aseptic fill/finish services and analytical support for Zafgen’s lead obesity treatment.

"Adding Zafgen to our growing list of strategic relationships with innovative pharmaceutical clients is an important milestone for Dalton,” said Peter Pekos, Dalton Pharma’s president and chief executive officer. “We are thrilled to be working with the Zafgen team and look forward to a successful collaboration as we advance this breakthrough obesity therapy through clinical development.”